baber/WOPTO huggingface dataset:
Patent NZ-565913-A (NZ)
Title: Drill bit screw tip with narrowed portion for controlled failure
Inventor: DURFEE LAVERNE
Filed: 2008-02-13
Abstract: A drill bit comprises a shank having a longitudinal axis. A cutting head is formed at one end of the shank. A removable and replaceable pilot tip such as a screw tip or pilot point is formed on the cutting head. The pilot tip is designed for controlled failure. A tool is also provided for removing the broken tip. A kit comprising a dill bit adapted to receive a removable tip, a removable tip for attachment to the cutting head, and/or a removal tool for removing a broken tip from the drill bit. A method for removing a tip from a drill bit and replacing it with another tip is also provided.
Patent NZ-570832-A (NZ)
Title: Resin nozzle with spring defining a path for a resin sausage through to a pre-drilled hole
Inventor: WILLIAMS MICHAEL DENE
IPC: E21D20/02
Filed: 2007-02-28
Abstract: Disclosed is a resin nozzle (2) adapted for securing resin set bolts into the ceilings and walls of a mine by injecting a resin sausage into a pre-drilled bolt hole. The nozzle includes a spring (16), a nozzle tip (12), and a connector member (20). The spring defines a path for the resin sausages to a pre drilled bolt hole. The nozzle tip connects to the same passage. The connector member is fastened onto rock bolting equipment to which resin sausages may be ejected therefrom.
Patent NZ-571240-A (NZ)
Title: Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
Inventor: GIOVANNONE DANIELE
IPC: A61K31/52
Filed: 2006-08-08
Abstract: Disclosed is a solid composition comprising SAMe and/or NADH or its salts in association with calcium oxide and optionally pharmaceutically acceptable excipients. A process for preparing the above composition is also disclosed, the process comprising the steps of: a) mixing of the SAMe and/or NADH and/or their salts with calcium oxide and pharmaceutically acceptable excipients, b) precompression and subsequent granulation of the mixture obtained in stage a), c) mixing of the granulate obtained in stage b) with pharmaceutically acceptable excipients, d) compression of the mixture obtained in stage c), with the optional addition of sweeteners and/or flavourings, e) optional coating of the solid composition obtained in stage d) with hydrogenated fatty acids, f) optional aqueous phase film-coating of the solid composition obtained in stage e).
Patent NZ-573064-A (NZ)
Title: Immunostimulatory G,U-containing oligoribonucleotides
Inventor: LIPFORD GRAYSON
IPC: A61K48/00
Filed: 2003-04-04
Abstract: Provided is a composition, comprising: a DNA: RNA conjugate, wherein DNA of the conjugate comprises a CpG motif effective for stimulating TLR9 signaling and RNA of the conjugate comprises RNA effective for stimulating signaling by TLR3, TLR7, TLR8, or any combination thereof, wherein the RNA is G,U-rich with at least 60% G and U. The compositions can be used as medicaments to induce an immune response in an animal. (62) Divided Out of 535952
Patent NZ-574479-A (NZ)
Title: Use of polyethylene glycol in inflammatory skin conditions and wound healing
Inventor: VAN DEN PLAS DAVE
IPC: A61K31/765
Filed: 2007-07-30
Abstract: Disclosed is the use of one or more forms of Polyethylene Glycol (PEG) with a Mr below 1500 as the sole anti-inflammatory component for the manufacture of a medicament in the form of a hydrogel or an aqueous solution comprising said one or more forms of Polyethylene Glycol (PEG) at a concentration between 0.5 and 5 percent (w/w), for the treatment of inflammation of the skin or mucosa
Patent NZ-583968-A (NZ)
Title: Respiratory system with a humidifier and a pre-conditioning system with a dewpoint controller
Inventor: BEDFORD JON RICHARD
IPC: F16L53/38
Filed: 2008-08-14
Abstract: Disclosed is a respiratory system for enhancing respiratory care patient comfort and compliance. The system has a humidifier system (41) comprising an inlet (52) for taking in a breathable gas and a humidification chamber connected to the inlet for heating and humidifying the breathable gas before delivery to a patient. A pre-conditioning system pre-conditions the breathable gas before entry into the humidification chamber in a controlled manner. The respiratory system comprises at least one dewpoint system for determining the dewpoint of the breathable gas and being in communication with a controller. The controller controlls the pre-conditioning system on the basis of the dewpoint determined by means of the dewpoint system.
Patent NZ-584597-A (NZ)
Title: Modified human growth hormone
Inventor: CHO HO SUNG
IPC: A61K38/27
Filed: 2005-12-21
Abstract: Provided is a hormone composition comprising human growth hormone (hGH) comprising a specified amino acid sequence with an amino acid substitution at position 35 thereof, said substitution being the replacement of tyrosine for a non-naturally encoded amino acid (NEAA), wherein said amino acid sequence is covalently linked to one 30kD linear polyethylene glycol (PEG) molecule via an oxime bond formed between the non-naturally encoded amino acid (NEAA) and the PEG molecule, and wherein said hormone composition is greater than 95% pure and has less than 5 EU endotoxin per dose, and wherein the hGH has an average serum half-life in a mammal to which it has been administered previously of at least about 7-fold the serum half-life of a composition comprising the GH without the PEG molecule attached.
Patent NZ-585777-A (NZ)
Title: Compositions and methods of enhancing immune responses to eimeria
Inventor: BOTTJE WALTER
IPC: A61K39/00
Filed: 2008-11-03
Abstract: Disclosed is a vaccine comprising a first polynucleotide sequence encoding a TRAP polypeptide or an immunogenic fragment thereof, wherein the TRAP polypeptide is SEQ ID NO: 2 or an immunogenic fragment thereof.
Patent NZ-589746-A (NZ)
Title: Method for manufacturing medicinal compounds containing dabigatran
Inventor: RADTKE GUIDO BERNHARD EDMUND
IPC: A61K9/16
Filed: 2009-07-13
Abstract: Disclosed herein is a process for preparing a suspension of the polymorph I of the methanesulphonic acid salt of dabigatran etexilate of formula I, characterised in that the polymorph I of dabigatran etexilate methanesulphonate being characterised by a melting point of 180°C ± 3°C (determined by DSC; heating rate: 10°C/min) is suspended together with talc in a solution of hydroxypropylcellulose in isopropyl alcohol, the preparation of the suspension being carried out at a temperature not exceeding 30°C by the circulatory dispersal process, wherein a dispersion device is connected to a batch container and the isopropyl alcohol is circulated through the batch container to generate a suction vacuum to suck in the hydroxypropylcellulose, the polymorph I of dabigatran etexilate methanesulphonate and the talc..
Patent NZ-591325-A (NZ)
Title: Plastic container having reinforced gripping structure
Inventor: HEISNER DAVID B
IPC: B65D1/02
Filed: 2009-08-19
Abstract: 591325 A plastic container (10) includes a generally cylindrical main body (16) portion having a longitudinal axis. At least one gripping recess is defined in the main body portion and that is defined in part by a curved concave inner surface when viewed in side elevation. The gripping recess includes first and second horizontal indentations (26, 28), each of which is sized to receive a finger of a consumer when the plastic container is being gripped by the consumer. The first horizontal indentation (26) extends a shorter horizontal distance than the second horizontal indentation (28). The gripping recess further comprises a convexly curved projection (36) as viewed in horizontal cross-section located between the first horizontal indentation and the second horizontal indentation.
Patent NZ-593883-A (NZ)
Title: Safety anchor device comprising an inflatable container that can be filled with water where a pair of walls are internall connected by drop threads so as to limit the seperation between them on inflation
Inventor: AUSTON OLIVER
IPC: A47C27/08
Filed: 2010-01-27
Abstract: A dead-weight anchor device 1 for securing a line 2 to a person working at height comprises a flexible-walled container 4 with an internal volume that may in 5 uses be inflated with a quantity of water to provide an anchoring dead-weight and subsequently deflated by letting the quantity of water escape from the container 4 when not in use. The container 4 has at least one attachment 36 for the line 2. The container 4 has a plurality of flexible walls10 -19, including a pair of walls 10,11 that are internally connected by drop threads 28 that limit the separation between the pair of walls 10,11 when the internal volume is inflated by the quantity of water.
Patent NZ-594599-A (NZ)
Title: Microencapsulated insecticide with enhanced residual activity
Inventor: WILSON STEPHEN
IPC: A01N25/02
Filed: 2010-03-01
Abstract: 594599 Disclosed herein is a method of formulating and using a microencapsulated insecticide with an extended field life after application of insecticidal activity. These methods include the steps of forming a microcapsule that includes at least one organophosphate insecticide and at least one non-volatile compound such as an esterified fatty acid that is at least partially surrounded by a polymer shell. These formulations can be used to control insect populations by singular or periodic applications of the microcapsule microencapsulated formulations to areas adjacent to insect populations. In a preferred embodiment the microencapsulated insecticidal formulation comprises chlorpyriphos-methyl, methyl oleate and a microcapsule shell comprising a polyurea.
Patent NZ-596733-A (NZ)
Title: Assembly for a drug delivery device and drug delivery device to prevent setting a dose greater than amount of drug remaining
Inventor: STREHL MICHAEL
IPC: A61M5/315
Filed: 2010-06-01
Abstract: An assembly is disclosed for a drug delivery device. The assembly comprises a housing (13), a dose member (23) displaceable in a proximal direction for setting a dose and a clutch member (28) which is also displaced in the proximal direction when setting the dose. A stop member (30) is configured to define a proximal clutch stop position where the clutch member (28) is prevented from further proximal displacement. The clutch member (28) and the dose member (23) mechanically cooperate when the clutch (28) member is in the stop position which prevents further proximal displacement of the dose member (23).
Patent NZ-597044-A (NZ)
Title: Medicinal carbohydrates for treatment of respiratory conditions
Inventor: JONES PAUL ARTHUR
IPC: A61K31/70
Filed: 2010-07-02
Abstract: Disclosed is the use of a compound capable of accelerating sialylglycoconjugate biosynthesis to restore sialylglycoconjugates on a surface of the respiratory cell. Compounds include the carbohydrate compounds of Formula (I) and (II), an in particular, include N-acetylmannosamine, N-acetylglucosamine, N-acetylneuraminic acid, and CMP-sialic acid.
Patent NZ-598947-A (NZ)
Title: Novel treated mineral pigments for aqueous based barrier coatings
Inventor: BERUBE RICHARD
IPC: C09D7/62
Filed: 2010-08-24
Abstract: A method for preparing an aqueous based coating system for coating onto paper and/or paperboard for providing barrier to liquid, moisture vapour, oil and grease is disclosed, which comprises the steps of:(a) surface treating a pigment with at least one material selected from the group consisting of stearates, hydrophobic ally-modified polyethylenimine, styrene-acrylic resin emulsion, styrene-butadiene latex emulsions, blends of styrene acrylic and styrene butadiene latex emulsions, silanes, siloxanes, and siloxane/silicone resin blends, and their carbon-based analogs, to form a pigment system, and (b) mixing a polymer emulsion system with a surface treated pigment system,wherein the polymer emulsion system is selected from the group consisting of styrene-acrylic resin emulsion, styrene-butadiene latex emulsions, and blends thereof, and wherein the pigment of the pigment system comprises at least one inorganic material selected from the group consisting of kaolin, bentonite, mica, talc, attapulgite, and zeolite.
Patent NZ-599667-A (NZ)
Title: Conformationally constrained, fully synthetic macrocyclic compounds
Inventor: OBRECHT DANIEL
IPC: A61K31/4745
Filed: 2010-08-03
Abstract: Disclosed are macrocyclic compounds according to formulae Ia or Ib, salts thereof, and methods for their preparation. Specific examples of Formulae Ia and Ib include: (2S,11S,19aS)-N-[2-(dimethylamino)ethyl]-15-fluoro-7,12-dimethyl-2-{ [(1-naphthylamino)carbonyl]amino} -5,S,13-trioxo-2,3,6,7,S,9,10,11,12,13,19,19a-dodecahydro-1H,5H-pyrro10[2,1-c][1,4,7,12]benzoxatriazacyclopentadecine1-carboxamide, N-[(45,65,10S)-14-methyl-6-[2-(2-naphthyl)acetyl]amino-9,15-dioxo-2-oxa-8,14-diazatricyclo[14.3.1.04,B]icosa-1(20),16,18-trien-10-yl]decanamide, and N-[(4S,6S,10S)-14-methyl-6-{ [2-(2-naphthyl)acetyl]amino} -9,15-dioxo-2-oxa-8,14-diazatricyclo[14.3.1.04,8]icosa-1(20),16,18-trien-10-yl]-6-phenylhexanamide. Compounds of formula Ia and Ib have agonistic or antagonistic activity on the motilin receptor (MR receptor), on the serotonin receptor of subtype 5-HT2B (5-HT2B receptor), on the prostaglandin F2alpha receptor (FP receptor) on the purinoreceptor P2Y1, on the voltage gated potassium channel Ky1.3, and on the canonical (beta-catenin-dependent) Wnt pathway. The compounds are useful for treating motility disorders of the gastrointestinal tract such as functional dyspepsia, diabetic gastroparesis or constipation type irritable bowel syndrome; of CNS related diseases like migraine, schizophrenia, psychosis, depression or Alzheimer disease; of ocular hypertension such as associated with glaucoma and of preterm labour; of CNS inflammatory disorders like multiple sclerosis; of thromboembolic disorders; of cell proliferation disorders, especially various cancer types; or of bone and cartilage-related disorders.
Patent NZ-602307-A (NZ)
Title: Deployable shelter structure
Inventor: FINCK WILLIAM
IPC: E04H15/08
Filed: 2011-05-18
Abstract: A shelter structure (3) arranged to be deployed from a stowed configuration to a deployed configuration is disclosed. A plurality of elongate stays (4) supporting a flexible awning (5), are pivoted from a central hub to fan out and form a canopy. The stays (4) are stowed in an elongate storage container (2) which is mounted or mountable to a vehicle (1). The hub is located near an end of the container (2) so that the stays (4) can be rotated out of the container (2) through an elongate opening in the side of the container (2).
Patent NZ-604743-A (NZ)
Title: Method for producing methane from biomass
Inventor: MARKER TERRY L
IPC: C10L3/00
Filed: 2011-06-09
Abstract: Disclosed is a method for producing methane from biomass comprising the steps of: a) hydropyrolyzing biomass in a hydropyrolysis reactor vessel containing molecular hydrogen and a deoxygenating catalyst, producing a hydropyrolysis product comprising char and vapors; b) separating said char from said hydropyrolysis product, producing a reduced char hydropyrolysis product; c) hydroconverting said reduced char hydropyrolysis product in a hydroconversion reactor vessel using a hydroconversion catalyst, producing a hydroconversion product; d) separating from said hydroconversion product condensed liquid water and a gaseous mixture comprising CO2, H2, and methane, wherein said gaseous mixture is free from char; and e) introducing at least a first portion of said gaseous mixture as a feed to a steam reformer, producing reformer CO2 and reformer H2, and f) introducing at least a second portion of said gaseous mixture to a methanation reactor, forming additional methane, wherein both hydropyrolyzing step a) and hydroconverting step c) are exothermic. Further disclosed is a hydropyrolysis process comprising: a) hydropyrolyzing biomass in a fluidized bed hydropyrolysis reactor in the presence of a deoxygenating catalyst and using a hydrogen-containing gas for fluidization to produce a hydropyrolysis product; b) hydroconverting the hydropyrolysis product in a hydroconversion reactor in the presence of a hydroconversion catalyst and hydrogen to produce a hydroconversion product; c) separating condensed liquid water and a gaseous mixture comprising CO2, H2, and methane from the hydroconversion product; and d) introducing at least a first portion of said gaseous mixture to a methane hydrate recovery process to produce a purified methane stream and hydrogen that is recycled to the hydropyrolysis reactor, wherein both hydropyrolyzing step a) and hydroconverting step b) are exothermic.
Patent NZ-611315-A (NZ)
Title: Intraocular lens transfer case
Inventor: BROWN KYLE
IPC: A61M5/31
Filed: 2013-01-17
Abstract: An intraocular lens (IOL) transfer case for transferring an IOL to an injection cartridge includes a lens holder for holding the IOL. The lens holder includes a bore. Folding members within the lens holder are configured to fold the IOL into a partially folded position when the IOL is slid through the bore across the folding members. The IOL transfer case also includes an interface configured to removably connect to an injection cartridge. The interface is positioned to deliver the IOL in the partially folded position within the injection cartridge when the interface is connected to the injection cartridge. The interface is configured to disconnect from the injection cartridge while leaving the IOL in the partially folded position to allow injection of the IOL. The IOL transfer case also includes a plunger connected to the lens holder. The plunger is configured to push the IOL in the partially folded position through the bore to deliver the IOL into the injection cartridge. The plunger is configured to stop within the injection cartridge before the IOL is completely folded.
Patent NZ-616099-A (NZ)
Title: 1,3-oxazines as bace1 and/or bace2 inhibitors
Inventor: NARQUIZIAN ROBERT
IPC: C07D413/12
Filed: 2012-05-11
Abstract: The present invention provides compounds of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer’s disease and type 2 diabetes. Examples of the compounds for formula (I) are: (S)-4-{ S-[(4-Chloro-l-difluoromethyl-lH-pyrazol-3-ylmethyl)-amino ]-2-fluoro-phenyl } -4-methyl-S,6-dihydro-4H-[1,3]oxazin-2-ylamine (4R,SR)-4-[S-(Cyclopropylmethyl-amino)-2-fluoro-phenyl]-S-fluoro-4-methyl-S,6-dihydro-4H[1,3]oxazin-2-ylamine 7-[3-((R)-2-Amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluorophenylamino]-6,7-dihydro-5H-[1]pyrindine-3-carbonitrile.
Patent NZ-618856-A (NZ)
Title: Method for operating a wind turbine
Inventor: DE BOER WOLFGANG
IPC: H02P9/10
Filed: 2010-03-23
Abstract: Method of operating a wind power installation is disclosed. The wind power installation is connected to an electrical supply network and is in operation when wind prevails above an initial speed and below a switch-off speed, the wind power installation feeds electrical energy into the supply network and more specifically with a frequency and voltage desired or required by the supply network. In operation of the wind power installation above a rated value or below the switch-off speed, the rotor of the wind power installation that has at least one rotor blade rotates, and connected to the rotor of the wind power installation is a generator driven by the rotor thereby to generate electrical energy. The wind power installation has means for measuring the frequency in the electrical supply network and the means for measuring the network frequency are connected to a control device for controlling operation of the wind power installation. The power delivered by the generator of the wind power installation to the network is increased quickly and for a short period above the currently prevailing power of the wind power installation such that: in a deadband range, namely a frequency range of the grid frequency between the grid setpoint frequency and a deadband frequency below it, the power is not altered, in a control band range, namely a frequency range of the grid frequency between the deadband frequency and a control band frequency below it, the power is increased as a function of a frequency deviation of the grid frequency from the deadband frequency, and in an underfrequency range, namely a frequency range of the grid frequency from the control band frequency downwards, the power is increased constantly by a maximum preset power increase. A method of controlling a wind park comprising at least two wind power installations, in which each wind power installation is controlled in accordance with the above described method is further disclosed. Also disclosed are a wind power installation adapted to carry out the above described method and a wind park wherein the wind park includes a plurality of the above described wind power installations and/or is adapted to carry out above described method.
Patent NZ-619620-A (NZ)
Title: Plaited glove
Inventor: HUGHES GRIFFITH W
IPC: A41D31/02
Filed: 2012-06-13
Abstract: A cut resistant glove (10) is provided having an inner surface (see through cut-out) and an outer surface (14) wherein the inner surface is adapted for contacting a hand of a user, and the inner surface is more visible while the user is wearing the glove. The glove includes a two layer knit fabric of a plaited construction including a first layer on the inner surface and a second layer on the outer surface. The outer surface is constructed from non-stretchable, cut resistant yarn (12), wherein the yarn has filaments that are generally parallel to one another and the inner surface is constructed from a stretchable, elastic yarn.
Patent NZ-623809-A (NZ)
Title: System and method for converting class ii hydrate reservoirs
Inventor: BALCZEWSKI JOHN T
IPC: E21B37/06
Filed: 2012-09-26
Abstract: Clathrate reservoirs of Class II are modified in order to improve the ability to produce hydrocarbons from them. Specifically a method for improving producibility of subsurface clathrate formation underlain by a mobile aquifer includes drilling a borehole to a depth providing access to the mobile aquifer and injecting a material into the mobile aquifer such that the material passes through pore spaces and forms a barrier underlying the clathrate formation and substantially impeding fluid flow from the mobile aquifer into contact with the clathrate formation.
Patent NZ-627454-A (NZ)
Title: 2-amino, 6-phenyl substituted pyrido [2,3-d] pyrimidine derivatives useful as raf kinase inhibitors
Inventor: ALLGEIER MATTHEW CARL
IPC: C07D471/04
Filed: 2013-03-05
Abstract: Disclosed is the compound 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (DP-4978 / LSN 3074753 / LY-3009120) or a pharmaceutically acceptable salt thereof which is a pan Raf Inhibitor. Also disclosed are crystalline forms of the compound. Further disclosed is a pharmaceutical composition comprising the compound, or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable carrier, for the treatment of cancer, particularly thyroid cancer, ovarian cancer, melanoma, acute myelogenous leukemia (AML), and colorectal cancer.
Patent NZ-700387-A (NZ)
Title: Data rates in mobile radio systems
Inventor: TREVOR JOHN LAUGHTON
IPC: H04W88/06
Filed: 2013-09-24
Abstract: Broadband networks for cellular operation are relatively short range and are deployed with infrastructure to serve the needs of a relatively high density of users. Land Mobile Radio (LMR) networks are relatively long range and deployed with infrastructure to serve a relatively low density of users. Methods are described which enable mobile devices to use an LMR network to coordinate operation of individual sectors in a broadband network to achieve higher data rates or use other aspects of the broadband network.